GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Todos Medical TOMDF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Todos Medical — daily TOMDF Delayed
Market value
$2,130
Last close × shares
Volume
750k
Shares, 4 Nov 2026

About Todos Medical

Its shares trade under the ticker TOMDF. It has been listed since 21 February 2017. In the fiscal year to 31 December 2022, it reported revenue of $7.7m and a net loss of $25.0m. At that date it held total assets of $15.3m and shareholders' equity of −$35.5m.

Todos Medical Ltd. engages in the development of patient-friendly blood tests for the screening of cancers. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy.

Figures and description from our data supplier, not checked against the company's own report.

More about Todos Medical →

How it makes its money

Revenue, year to 31 Dec 2021

  • COVID-19 Testing [Member] $12.2m · 100.0%

Latest on Todos Medical

Our reporting

We have not reported on Todos Medical yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Todos Medical's ticker?

Todos Medical trades as TOMDF on its US listing, under ISIN IL0011392375.

What was Todos Medical's last closing price?

0.00 on 4 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.